Growing community of inventors

Gregory, MI, United States of America

Sharron Ladd

Average Co-Inventor Count = 5.25

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 67

Sharron LaddChristina N Carrigan (7 patents)Sharron LaddDaniel J Tavares (5 patents)Sharron LaddLingyun Rui (5 patents)Sharron LaddOlga Ab (5 patents)Sharron LaddJulianto Setiady (4 patents)Sharron LaddGillian Payne (2 patents)Sharron LaddKathleen R Whiteman (2 patents)Sharron LaddJuliantro Setiady (1 patent)Sharron LaddSharron Ladd (7 patents)Christina N CarriganChristina N Carrigan (11 patents)Daniel J TavaresDaniel J Tavares (53 patents)Lingyun RuiLingyun Rui (35 patents)Olga AbOlga Ab (20 patents)Julianto SetiadyJulianto Setiady (12 patents)Gillian PayneGillian Payne (19 patents)Kathleen R WhitemanKathleen R Whiteman (3 patents)Juliantro SetiadyJuliantro Setiady (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Immunogen, Inc. (7 from 255 patents)


7 patents:

1. 11932701 - Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate

2. 11198736 - Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody

3. 11135305 - Methods for increasing efficacy of FOLR1 cancer therapy

4. 10544230 - Methods of using antibodies to detect folate receptor 1 (FOLR1)

5. 10017578 - Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies

6. 9637547 - Monoclonal antibodies for detection of folate receptor 1

7. 8709432 - Methods for increasing efficacy of FOLR1 cancer therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…